Copy
Information on London enrolment for adults with Down syndrome into Roche multicenter trial.
Down Syndrome Research Foundation UK

London enrolment for Roche clinical trial 

We are excited to let you know that the recently announced Roche clinical trial is taking place in the UK too. Dr Andre Strydom at University College London is studying a medication that is being developed to improve attention and memory in people with Down Syndrome.

It is a multi-center, randomized, double-blind, placebo-controlled, multiple dose study to investigate safety and tolerability of RG1662 in individuals with Down Syndrome.  We are pleased that Roche have extended enrolment to London.  
 
Dr Strydom can be contacted at a.strydom@ucl.ac.uk ; or on +44 (0)2076799467 and please leave a message

US Charity DSRTF recently hosted an evening discussing this trial which can be viewed

Roche Clinical Trial Protocol Registry

P
lease contact Dr Strydom for more information and to discuss being involved with this study.

Leaflet available here
Copyright © 2012 Down's Syndrome Research Foundation, All rights reserved.
Email Marketing Powered by Mailchimp